OncLive
OncLive TV provides short, focused interviews with key oncology thought leaders. This unique platform allows oncology professionals to learn about important developments directly from their peers.
The Need for Decision Support in Oncology: Episode 3
The Need for Decision Support in Oncology: Episode 2
The Need for Decision Support in Oncology: Episode 1
Reviewing the Relevance of Ovarian Cancer Clinical Trials: Episode 3
Reviewing the Relevance of Ovarian Cancer Clinical Trials: Episode 2
Reviewing the Relevance of Ovarian Cancer Clinical Trials: Episode 1
The Inadequacy of Toxicity Reporting in Clinical Trials: Episode 4
The Inadequacy of Toxicity Reporting in Clinical Trials: Episode 3
The Inadequacy of Toxicity Reporting in Clinical Trials: Episode 2
The Inadequacy of Toxicity Reporting in Clinical Trials: Episode 1
Precision Cancer Medicine: From Potential to Possibility: Episode 3
Precision Cancer Medicine: From Potential to Possibility: Episode 2
Precision Cancer Medicine: From Potential to Possibility: Episode 1
Dr Reckamp on the Future Implications of the PRAGMATICA-LUNG Trial in Lung Cancer
Dr Das on Updates to the Standard First-Line Treatment Paradigm for ES-SCLC
Dr Jänne on Second-Line Treatment Evolutions in EGFR-Mutated NSCLC
Dr Mok on Choosing Between First-Line Therapies for BRAF-Mutant NSCLC
Dr Nieva on the Rationale for Comparing ALK Inhibitors in ALK+ NSCLC
Dr Patel on Toxicities Associated With Immunotherapy-Based Combinations in NSCLC
Untangling ASCO 2025 Data in Oncology: Episode 4
Dr Shum on Evolving First-Line Treatment Approaches for EGFR-Mutant NSCLC
Dr Donington on the Evolving Use of Perioperative Nivolumab in Resectable NSCLC
Untangling ASCO 2025 Data in Oncology: Episode 3
Untangling ASCO 2025 Data in Oncology: Episode 2
Untangling ASCO 2025 Data in Oncology: Episode 1
Clinical Judgment: Optimal Care vs Selection Bias in Oncology: Episode 3
Clinical Judgment: Optimal Care vs Selection Bias in Oncology: Episode 2
Dr Scarfò on Updated Safety Data With BGB-16673 in Relapsed/Refractory CLL/SLL
Dr Dimopoulos on Elranatamab Plus Daratumumab and Lenalidomide in Myeloma
Dr Curtis on Cyclophosphamide GVHD Prophylaxis in Matched Donor Transplant